China Lymphedema Treatment Market: Is Cancer Survivorship the Hidden Driver Reshaping Lymphedema Treatment Demand?
The dramatic expansion of cancer survival rates in China over the past two decades, driven by improved early detection programs, more sophisticated oncological treatment, and broader access to modern cancer therapy across the country's tertiary hospital network, has created a rapidly growing population of cancer survivors who carry the long-term health consequences of their cancer treatments...
0 Commentarii
0 Distribuiri
85 Views